ISOLATION, CHARACTERIZATION AND ANTI-TUMOUR PROPERTIES OF NOVEL CHIRAL ORGANOTIN (IV) COMPLEXES OF PHENANTHROLINES
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
ISOLATION, CHARACTERIZATION AND ANTI-TUMOUR PROPERTIES OF NOVEL CHIRAL ORGANOTIN (IV) COMPLEXES OF PHENANTHROLINES ; volume:10 ; number:2-3 ; year:2004 ; pages:181-186
Heterocyclic communications ; 10, Heft 2-3 (2004), 181-186
- Urheber
-
Chaudhary,, Ashu
Phor,, Anita
Gaur,, Shweta
Singh,, R.V.
- DOI
-
10.1515/HC.2004.10.2-3.181
- URN
-
urn:nbn:de:101:1-2501130351134.274990307071
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chaudhary,, Ashu
- Phor,, Anita
- Gaur,, Shweta
- Singh,, R.V.
Ähnliche Objekte (12)
Acid affairs in anti-tumour immunity
Ruthenacarborane complexes as building blocks for the design of novel anti-tumour agents
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Acid affairs in anti-tumour immunity
Ruthenacarborane complexes as building blocks for the design of novel anti-tumour agents
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy
A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer
Acid affairs in anti-tumour immunity
Ruthenacarborane complexes as building blocks for the design of novel anti-tumour agents
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth
Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response
Glutarate regulates T cell metabolism and anti-tumour immunity
Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity
Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response
Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity
Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy